Skip to main content
Gland Pharma Limited logo

Gland Pharma Limited — Investor Relations & Filings

Ticker · GLAND ISIN · INE068V01023 LEI · 335800JJVDY5R6KF5K34 BSE.NS Manufacturing
Open in API
Filings indexed 676 across all filing types
Latest filing 2026-05-14 Declaration of Voting R…
Country IN India
Listing BSE.NS GLAND

About Gland Pharma Limited

https://glandpharma.com

Gland Pharma Limited is a specialized Contract Development and Manufacturing Organization (CDMO) focused on injectable formulations. The company operates primarily through a business-to-business (B2B) model, providing development and manufacturing services for a diverse range of sterile injectables. Its portfolio encompasses complex generics across various therapeutic areas, including oncology, ophthalmology, anti-infectives, and orthopedics. Gland Pharma maintains a vertically integrated supply chain, ensuring control over critical raw materials and active pharmaceutical ingredients. The company serves a global market, with a significant presence in regulated regions such as the United States, Europe, Canada, and Australia. Its manufacturing facilities adhere to international quality standards and hold approvals from major regulatory bodies. Key strengths include expertise in niche segments like heparin and enoxaparin, alongside a robust pipeline of complex delivery systems.

Recent filings

Filing Released Lang Actions
Outcome of Postal Ballot
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is an official communication to stock exchanges reporting the results of a shareholder vote conducted by postal ballot (remote e-voting) under SEBI Listing Regulations. It includes the voting tallies, resolution details, and a scrutinizer’s report. This matches the definition for Declaration of Voting Results & Voting Rights Announcements (Code: DVA).
2026-05-14 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 92% confidence The document is a formal communication to stock exchanges disclosing the results of a postal ballot (remote e-voting) for a special resolution, including detailed vote counts and a scrutinizer’s report, pursuant to SEBI Listing Regulations. This aligns with the definition of "Declaration of Voting Results & Voting Rights Announcements" (Code: DVA).
2026-05-14 English
Intimation regarding ESOP Compensation Committee Meeting
Regulatory Filings Classification · 78% confidence The document is a brief letter to stock exchanges notifying them of the upcoming ESOP Compensation Committee meeting to consider a grant of stock options. It does not contain financial data, an actual report, a dividend notice, management changes, or a share issue execution; it’s a regulatory/intimation announcement. No specific category for an ESOP meeting notice exists, so it falls under the general Regulatory Filings (RNS) category.
2026-05-12 English
Updates
Regulatory Filings Classification · 75% confidence The document is a short notice to stock exchanges informing them of an upcoming ESOP Compensation Committee meeting. It does not contain financial results, management changes, or a report attachment. It is a general regulatory announcement for compliance purposes, fitting the Regulatory Filings (RNS) category.
2026-05-12 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings Classification · 95% confidence The document is a declaration under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. It pertains to the promoter and promoter group declaring no encumbrance on shares held, with reference to share pledging status. The document is addressed to stock exchanges and the company secretary, and it is a formal regulatory declaration related to shareholding and encumbrance status. It does not contain financial statements, management discussion, or report content. It is not a report or announcement of financial results, nor a meeting material. It is a regulatory filing related to shareholding disclosures under SEBI regulations, which fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other categories.
2026-04-30 English
Updates
Board/Management Information Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the reappointment of Ms. Naina Lal Kidwai as an Independent Director. It references a prior postal ballot notice and clarifies the approval process for remuneration exceeding 50% of total Non-Executive Directors' pay. There is no financial data, no report attached or referenced as being published, and no mention of financial results or regulatory certifications. The content focuses on board/management changes and related governance matters. Therefore, the document fits best under Board/Management Information (MANG). The document length is short and does not contain financial statements or detailed management discussion, so it is not an Annual Report or Management Report. It is not a voting result announcement or proxy solicitation. Hence, the classification is MANG with high confidence.
2026-04-27 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.